For Alzheimer’s Scientists, the Amyloid Debate Has No Easy Answers

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

For years, potential therapies that attack this brain protein have failed to help patients in clinical trials. Now—surprisingly—a new drug shows promise.

Visit the podcast's native language site